You are currently viewing a new version of our website. To view the old version click .

Cervical Cancer Screening and Treatment in the 21st Century

Special Issue Information

Dear Colleagues,

Cervical cancer used to be a common, often lethal malignancy for women. In the last century, due to many revolutionary developments in research, this oncologic entity can currently be prevented, diagnosed in early stages and treated well in advanced stages.  Through systematic cytology and HPV DNA testing, cervical cancer has become very rare in high-resource countries. Detection and staging through high-resolution imaging and the most recent generation of contrast dye and tracers, robotic and laparoscopic surgery, image-guided radiation therapy, chemotherapy combined with targeted agents or immune therapy improve the outcome of this cancer tremendously. The development of the anti-HPV vaccine raises hope that by 2050 this cancer type will become history.

This Special Issue will address the latest developments in the screening and contemporary treatment of cervical cancer.

Dr. Alina E. Sturdza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HPV testing
  • laparoscopic lymph node staging
  • targeted therapy
  • image-guided radiotherapy
  • HPV vaccine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers